Please login to the form below
Medmeme bolsters its sales team
Franco Barbalinardo joins as senior vice president, sales and business
Medical affairs solutions group Medmeme has appointed Franco Barbalinardo as its senior vice president for sales and business, following more than 20 years’ healthcare experience.
Barbalinardo’s background includes roles on both the manufacturer and vendor side and his expertise spans across the commercial, analytics, medical affiars, R&D and life science functions.
He joins the group from Carson Analytics, where he was senior vice president of sales and marketing, responsible for re-branding an re-launching the company.
Mahesh Naithani, founder of Medmeme, said: “Franco is ideally placed to drive sales for Medmeme’s unique offering which can yield transformative and market-differentiating benefits for pharma and other healthcare organisations.”
Barbalinardo has also held roles for Aileron Solutions – which was acquired by IMS Health in 2014 -, Within3, and Pfizer.
Naithani added: “We are very pleased to welcome Franco to our team and we look forward to working with him.”
COVID-19 Updates and Daily News
Featured jobs
-
Senior Health Psychologist, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
-
Head of Health Psychology, London
-
Highly competitive salary
- Scientists discover new approach to treat brain tumours
- Recognising HIV Vaccine Awareness Day
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- J&J appoints Thibaut Mongon as CEO designate of New Consumer Health Company
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients
- Live Webinar: The Future of MedTech: Streamlined Clinical Data Collection & Management
- Medscape: Connect to the conversation
- A Medscape 4-part video interview series
- Why big pharma needs to be braver
- MadMicrobe Studios Inc Announces New European Venture
- EMA accepts Valneva’s marketing authorisation application for COVID-19 vaccine
PMHub
VISFO
A team of strategic decision specialists with over 30+ years in the pharma space, we give you confidence through experience....
Latest intelligence
- Why big pharma needs to be braver
- The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
- Food Allergy – Is avoidance the only option?
- Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
